Byterna Therapeutics

BiotechnologyAngelShanghai, Chinabyterna.com

Latest round

Angel

Last raised

Dec 2025

Total raised

Undisclosed

Investors

3

About Byterna Therapeutics

, trading as Byterna Therapeutics, specializes in biotechnology, particularly in mRNA-based therapies. Byterna Therapeutics offers a range of mRNA-based therapies designed to improve cancer treatment outcomes. The company is currently advancing its clinical research in the IIT pipeline for BR101, a circular mRNA (cmRNA)-based CAR-T therapy, targeting healthcare providers and research institutions focused on oncology. The company's revenue generation is primarily structured through a subscription model for access to its mRNA therapies and related services.

Who invested in Byterna Therapeutics

3 investors across 2 rounds

See all investors in Byterna Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Dec 15, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Nov 17, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Byterna Therapeutics

Who invested in Byterna Therapeutics?

Byterna Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Byterna Therapeutics raised?

Byterna Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Byterna Therapeutics last raise money?

Byterna Therapeutics's most recent round on record is a Angel, in Dec 2025.

What does Byterna Therapeutics do?

, trading as Byterna Therapeutics, specializes in biotechnology, particularly in mRNA-based therapies.

Where is Byterna Therapeutics headquartered?

Byterna Therapeutics is headquartered in Shanghai, China.

Which VCs invest in companies like Byterna Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Byterna Therapeutics's stage. Their profiles are linked below.

Raising like Byterna Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.